Research summary ·
Risk factors for idiopathic pulmonary fibrosis: an umbrella review of meta-analyses and mendelian randomization analyses.
Written based on 1 research study on PubMed, searched on 5 Nov 2026.
What was studied
This umbrella review pooled evidence on risk factors for idiopathic pulmonary fibrosis, or IPF. It covered earlier meta-analyses and Mendelian randomization (MR) studies. The team searched 8 databases up to March 11, 2025. It rated the meta-analyses with AMSTAR-2. It rated the MR studies with STROBE-MR. It sorted the evidence into levels of trust.
What they found
8 meta-analyses reported 22 links. 12 were rated suggestive and 10 weak. The overall trust in this evidence was relatively low. The 36 MR studies covered 124 links. 13 were rated robust, 90 possible, 17 suggestive and 4 insufficient. The pooled analysis found 108 links. The meta-analyses were of low or critically low quality. The MR studies had good reporting.
What it means for patients
The authors say the review lays out the evidence on several kinds of factors. These are genes, viral infections, work and environment exposures, lifestyle and clinical factors. They say it gives a base for IPF risk research. They say it supports clinical decisions and public health plans.
Why it is not certain yet
The meta-analyses were of low quality. Trust in their evidence was relatively low. Earlier studies had given mixed findings. The abstract does not name which factors were rated robust.
Source
Risk factors for idiopathic pulmonary fibrosis: an umbrella review of meta-analyses and mendelian randomization analyses.
PubMed · PMID 42806316We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Idiopathic pulmonary fibrosis publications